Inactivation and reactivation of hexokinase type II.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000201:enzymology; D002848:Chromatography, DEAE-Cellulose; D003920:Diabetes Mellitus / Q000139:chemically induced / Q000201:enzymology; D004355:Drug Stability; D004789:Enzyme Activation / Q000187:drug effects; D005947:Glucose / Q000494:pharmacology; D005958:Glucosephosphates / Q000494:pharmacology; D006593:Hexokinase / Q000378:metabolism*; D007700:Kinetics; D008623:Mercaptoethanol / Q000494:pharmacology; D009206:Myocardium / Q000201:enzymology; D010710:Phosphates / Q000494:pharmacology; D011485:Protein Binding; D011487:Protein Conformation; D011489:Protein Denaturation; D051381:Rats; D013311:Streptozocin; D013997:Time Factors; D014357:Trypsin
D005958:Glucosephosphates; D010710:Phosphates; D013311:Streptozocin; D008623:Mercaptoethanol; D000244:Adenosine Diphosphate; D006593:Hexokinase; D014357:Trypsin; D005947:Glucose